Blood Purification Treatments in COVID-19
Yıl: 2020 Cilt: 11 Sayı: 1 Sayfa Aralığı: 32 - 35 Metin Dili: İngilizce DOI: 10.37678/dcybd.2020.2436 İndeks Tarihi: 09-12-2020
Blood Purification Treatments in COVID-19
Öz: Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged for the first time in Wuhan, China,in December 2019. These viruses mainly cause respiratory and intestinal infections and induce a variety ofclinical manifestations (1, 2). High virus titer and the subsequent strong inflammatory cytokine and chemokineresponses are related to the high morbidity and mortality observed during the pathogenic HCoV infection.Blood purification system including plasma exchange, adsorption, perfusion, blood/plasma filtration, etc., canremove inflammatory factors, block the "cytokine storm", to reduce the damage of inflammatory responseto the body. This therapy can be used for severe and critical patients in the early and middle stages of thedisease (3). We recommend not using Extracorporeal treatments based on cytokine and / or endotoxin removalroutinely in patients infected with COVID-19 due to insufficient studies (4).
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Peck KM, Burch CL, Heise MT et al: Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives. Annu Rev Virol 2015, 2:95-117.
- 2. Su S, Wong G, Shi W et al: Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016, 24:490- 502.
- 3. Xu K, Cai H, Shen Y et al: [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020, 49:0.
- 4. Monard C, Rimmele T, Ronco C et al: Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif 2019, 47 Suppl 3:1-14.
- 5. Lai CC, Shih TP, Ko WC et al: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020, 55:105924.
- 6. D'Elia RV, Harrison K, Oyston PC et al: Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol 2013, 20:319- 327.
- 7. Prince LR, Whyte MK, Sabroe I et al: The role of TLRs in neutrophil activation. Curr Opin Pharmacol 2011, 11:397-403.
- 8. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
- 9. Law HK, Cheung CY, Ng HY et al: Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 2005, 106:2366-2374.
- 10. Meduri GU, Kohler G, Headley S et al: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
- 11. Ye Q, Wang B, Mao J: The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect 2020, 80:607-613.
- 12. Fernandez-Zarzoso M, Gomez-Segui I, de la Rubia J: Therapeutic plasma exchange: Review of current indications. Transfus Apher Sci 2019, 58:247-253.
- 13. Schwartz J, Padmanabhan A, Aqui N et al: Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher 2016, 31:149- 162.
- 14. Karr EG, Neyrinck, M.M. et al : Therapeutic apheresis procedures. Principles of apheresis technology 2017:53-63.
- 15. Kinjo N, Hamada K, Hirayama C et al: Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome. J Clin Apher 2018, 33:117-120.
- 16. Knaup H, Stahl K, Schmidt BMW et al: Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care 2018, 22:285.
- 17. Busund R, Koukline V, Utrobin U et al : Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002, 28:1434-1439.
- 18. Shiga H, Hirasawa H, Nishida O et al : Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif 2014, 38:211-218.
- 19. Kobashi S, Maruhashi T, Nakamura T et al : The 28-day survival rates of two cytokine-adsorbing hemofilters for continuous renal replacement therapy: a single-center retrospective comparative study. Acute Med Surg 2019, 6:60-67.
- 20. Malard B, Lambert C, Kellum JA: In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp 2018, 6:12.
- 21. Klein DJ, Foster D, Walker PM et al : Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med 2018, 44:2205-2212.
- 22. Chang T, Tu YK, Lee CT et al : Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis. Crit Care Med 2017, 45:e858-e864.
- 23. Adamik B, Zielinski S, Smiechowicz J et al : Endotoxin Elimination in Patients with Septic Shock: An Observation Study. Arch Immunol Ther Exp (Warsz) 2015, 63:475-483.
- 24. Yaroustovsky M, Abramyan M, Popok Z et al : Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay. Blood Purif 2009, 28:227-233.
- 25. Lipcsey M, Tenhunen J, Sjolin J et al : Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco(R) LPS Adsorber: study protocol for a double-blinded, randomized placebocontrolled trial. Trials 2016, 17:587.
- 26. Kellum JA, Johnson JP, Kramer D et al : Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26:1995-2000.
- 27. Joannes-Boyau O, Honore PM, Perez P et al: High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013, 39:1535-1546.
- 28. Borthwick EM, Hill CJ, Rabindranath KS et al : High-volume haemofiltration for sepsis in adults. Cochrane Database Syst Rev 2017, 1:CD008075.
- 29. Clark E, Molnar AO, Joannes-Boyau O et al : High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 2014, 18:R7.
| APA | Temel Ş, Sungur M (2020). Blood Purification Treatments in COVID-19. , 32 - 35. 10.37678/dcybd.2020.2436 |
| Chicago | Temel Şahin,Sungur Murat Blood Purification Treatments in COVID-19. (2020): 32 - 35. 10.37678/dcybd.2020.2436 |
| MLA | Temel Şahin,Sungur Murat Blood Purification Treatments in COVID-19. , 2020, ss.32 - 35. 10.37678/dcybd.2020.2436 |
| AMA | Temel Ş,Sungur M Blood Purification Treatments in COVID-19. . 2020; 32 - 35. 10.37678/dcybd.2020.2436 |
| Vancouver | Temel Ş,Sungur M Blood Purification Treatments in COVID-19. . 2020; 32 - 35. 10.37678/dcybd.2020.2436 |
| IEEE | Temel Ş,Sungur M "Blood Purification Treatments in COVID-19." , ss.32 - 35, 2020. 10.37678/dcybd.2020.2436 |
| ISNAD | Temel, Şahin - Sungur, Murat. "Blood Purification Treatments in COVID-19". (2020), 32-35. https://doi.org/10.37678/dcybd.2020.2436 |
| APA | Temel Ş, Sungur M (2020). Blood Purification Treatments in COVID-19. Journal of critical and intensive care (Online), 11(1), 32 - 35. 10.37678/dcybd.2020.2436 |
| Chicago | Temel Şahin,Sungur Murat Blood Purification Treatments in COVID-19. Journal of critical and intensive care (Online) 11, no.1 (2020): 32 - 35. 10.37678/dcybd.2020.2436 |
| MLA | Temel Şahin,Sungur Murat Blood Purification Treatments in COVID-19. Journal of critical and intensive care (Online), vol.11, no.1, 2020, ss.32 - 35. 10.37678/dcybd.2020.2436 |
| AMA | Temel Ş,Sungur M Blood Purification Treatments in COVID-19. Journal of critical and intensive care (Online). 2020; 11(1): 32 - 35. 10.37678/dcybd.2020.2436 |
| Vancouver | Temel Ş,Sungur M Blood Purification Treatments in COVID-19. Journal of critical and intensive care (Online). 2020; 11(1): 32 - 35. 10.37678/dcybd.2020.2436 |
| IEEE | Temel Ş,Sungur M "Blood Purification Treatments in COVID-19." Journal of critical and intensive care (Online), 11, ss.32 - 35, 2020. 10.37678/dcybd.2020.2436 |
| ISNAD | Temel, Şahin - Sungur, Murat. "Blood Purification Treatments in COVID-19". Journal of critical and intensive care (Online) 11/1 (2020), 32-35. https://doi.org/10.37678/dcybd.2020.2436 |
